Liao et al. found that SERPIND1 was overexpressed in non-small cell lung cancer (NSCLC), and that patients whose cancer tissues had higher SERPIND1 expression experienced a higher recurrence rate and a shorter overall survival than patients with lower SERPIND1 expression (22). Here, SERPIND1 is linked to non-small cell lung carcinoma.